Advertisement
Advertisement
U.S. markets open in 5 hours 1 minute
Advertisement
Advertisement
Advertisement
Advertisement

Captor Therapeutics SA (60Q.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
30.100.00 (0.00%)
As of 09:15AM CEST. Market open.
Advertisement
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2021
12/31/2020
12/31/2019
Total Revenue
4,616
3,986
0
0
Cost of Revenue
1,388
741
-
0
Gross Profit
3,228
3,245
0
0
Operating Expense
44,208
34,953
12,216
7,855
Operating Income
-40,980
-31,708
-12,216
-7,855
Net Non Operating Interest Income Expense
818
-807
-393
-428
Pretax Income
-40,281
-32,572
-12,694
-8,306
Tax Provision
0
0
0
0
Net Income Common Stockholders
-40,281
-32,572
-12,694
-8,306
Diluted NI Available to Com Stockholders
-40,281
-32,572
-12,694
-8,306
Basic EPS
-
-7.89
-3.91
-2.55
Diluted EPS
-
-7.89
-3.91
-2.55
Basic Average Shares
-
4,128
3,248
3,256
Diluted Average Shares
-
4,357
3,256
3,256
Total Operating Income as Reported
-40,981
-31,709
-12,216
-7,855
Total Expenses
45,596
35,694
12,216
7,855
Net Income from Continuing & Discontinued Operation
-40,281
-32,572
-12,694
-8,306
Normalized Income
-40,281
-32,572
-12,694
-8,306
Interest Income
1,128
0
0
2
Interest Expense
303
400
393
430
Net Interest Income
818
-807
-393
-428
EBIT
-39,978
-32,172
-12,301
-7,876
EBITDA
-32,675
-
-
-
Reconciled Cost of Revenue
1,388
741
-
0
Reconciled Depreciation
7,303
7,355
6,602
4,458
Net Income from Continuing Operation Net Minority Interest
-40,281
-32,572
-12,694
-8,306
Total Unusual Items Excluding Goodwill
0
0
0
-
Total Unusual Items
0
0
0
-
Normalized EBITDA
-32,675
-24,817
-5,699
-3,418
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
Advertisement
Advertisement